Health News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

Author: Australian Business

NATICK, Mass., Sept. 12, 2013 /PRNewswire/ -- In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY™ Stent System, Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the EVOLVE II randomized, controlled clinical......

More...

More Articles...

Actavis Launches Generic Version of Opana® ER
Alvi Armani Hair Loss Research Discontinues 'Hair Cloning' Research. Hair Replication Not a Feasible Technology. To Focus on Patented Origenere TR1 Natural Plant Extract for Hair Growth.
Illinois Lottery Kicks Off New 'Carolyn Adams Ticket for the Cure' Instant Game
FeverAll® Acetaminophen Suppositories Offer A Great Choice For Hispanic Moms Of Small Children
Stress Urinary Incontinence From Mesh Implant?
Siemens Canada awarded order by City of Calgary to provide next generation of LRT vehicles
Obesity Statistics for Mexico and the U.S. Point to Increasing Need for Bariatric Procedures in the Latino Community, says Dr. Feiz and Associates
Mushrooms And Health Summit Unearths Health And Nutritional Benefits Of Mushrooms
Bullet Bio Provides Update On Recent Financing And Results From Proof-Of-Concept Study For Lead Product Candidate
2013 Emmy Nominated Recording Artist, Andrew McMahon, To Perform At Global Genes | RARE Project's Sold Out Tribute to Champions of Hope™ Benefit

Page 1768 of 1908